Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52


A candidate androgen signalling signature predictive of response to abiraterone acetate in men with metastatic castration-resistant prostate cancer.

Boukovala M, Spetsieris N, Weldon JA, Tsikkinis A, Hoang A, Aparicio A, Tu SM, Araujo JC, Zurita AJ, Corn PG, Pagliaro L, Kim J, Wang J, Subudhi SK, Tannir NM, Logothetis CJ, Troncoso P, Wen S, Efstathiou E.

Eur J Cancer. 2020 Mar;127:67-75. doi: 10.1016/j.ejca.2019.12.027. Epub 2020 Jan 24.


A Phase II Study of Cabozantinib and Androgen Ablation in Patients with Hormone-Naïve Metastatic Prostate Cancer.

Corn PG, Zhang M, Nogueras-Gonzalez GM, Xiao L, Zurita AJ, Subudhi SK, Tu SM, Aparicio AM, Coarfa C, Rajapakshe K, Huang S, Navone NM, Lin SH, Wang G, Ramachandran S, Titus MA, Panaretakis T, Gallick GE, Efstathiou E, Troncoso P, Logothetis C.

Clin Cancer Res. 2020 Jan 15. doi: 10.1158/1078-0432.CCR-19-2389. [Epub ahead of print]


Differences in Tumor Microenvironment Dictate T Helper Lineage Polarization and Response to Immune Checkpoint Therapy.

Jiao S, Subudhi SK, Aparicio A, Ge Z, Guan B, Miura Y, Sharma P.

Cell. 2019 Nov 14;179(5):1177-1190.e13. doi: 10.1016/j.cell.2019.10.029.


Autoimmune antibodies correlate with immune checkpoint therapy-induced toxicities.

Tahir SA, Gao J, Miura Y, Blando J, Tidwell RSS, Zhao H, Subudhi SK, Tawbi H, Keung E, Wargo J, Allison JP, Sharma P.

Proc Natl Acad Sci U S A. 2019 Oct 29;116(44):22246-22251. doi: 10.1073/pnas.1908079116. Epub 2019 Oct 14.


Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1-2 trial.

Corn PG, Heath EI, Zurita A, Ramesh N, Xiao L, Sei E, Li-Ning-Tapia E, Tu SM, Subudhi SK, Wang J, Wang X, Efstathiou E, Thompson TC, Troncoso P, Navin N, Logothetis CJ, Aparicio AM.

Lancet Oncol. 2019 Oct;20(10):1432-1443. doi: 10.1016/S1470-2045(19)30408-5. Epub 2019 Sep 9. Erratum in: Lancet Oncol. 2020 Jan;21(1):e14.


Characterization and Comparison of GITR Expression in Solid Tumors.

Vence L, Bucktrout SL, Fernandez Curbelo I, Blando J, Smith BM, Mahne AE, Lin JC, Park T, Pascua E, Sai T, Chaparro-Riggers J, Subudhi SK, Scutti JB, Higa MG, Zhao H, Yadav SS, Maitra A, Wistuba II, Allison JP, Sharma P.

Clin Cancer Res. 2019 Nov 1;25(21):6501-6510. doi: 10.1158/1078-0432.CCR-19-0289. Epub 2019 Jul 29.


New approaches to immunotherapy for metastatic castration-resistant prostate cancer.

Subudhi SK.

Clin Adv Hematol Oncol. 2019 May;17(5):283-286. No abstract available.


Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis.

Abu-Sbeih H, Ali FS, Naqash AR, Owen DH, Patel S, Otterson GA, Kendra K, Ricciuti B, Chiari R, De Giglio A, Sleiman J, Funchain P, Wills B, Zhang J, Naidoo J, Philpott J, Gao J, Subudhi SK, Wang Y.

J Clin Oncol. 2019 Oct 20;37(30):2738-2745. doi: 10.1200/JCO.19.00320. Epub 2019 Jun 4.


Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers-Response.

Sharma A, Subudhi SK, Blando J, Vence L, Wargo J, Allison JP, Ribas A, Sharma P.

Clin Cancer Res. 2019 Jun 1;25(11):3469-3470. doi: 10.1158/1078-0432.CCR-19-0402. No abstract available.


Micronuclei in Exfoliated Cells: A Biomarker of Genotoxicity in Tobacco Users.

Upadhyay M, Verma P, Sabharwal R, Subudhi SK, Jatol-Tekade S, Naphade V, Choudhury BK, Sahoo PD.

Niger J Surg. 2019 Jan-Jun;25(1):52-59. doi: 10.4103/njs.NJS_10_18.


Quantitative analysis of AgNOR counts and pap stain in exfoliative cytology specimens of oral mucosa in bidi smokers and nonsmokers.

Vyas T, Verma P, Abidullah M, Kushwaha SS, Sahoo PK, Priyadarshini SR, Subudhi SK, Rana V.

Ann Afr Med. 2018 Oct-Dec;17(4):210-214. doi: 10.4103/aam.aam_69_17.


Author Correction: Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis.

Wang Y, Wiesnoski DH, Helmink BA, Gopalakrishnan V, Choi K, DuPont HL, Jiang ZD, Abu-Sbeih H, Sanchez CA, Chang CC, Parra ER, Francisco-Cruz A, Raju GS, Stroehlein JR, Campbell MT, Gao J, Subudhi SK, Maru DM, Blando JM, Lazar AJ, Allison JP, Sharma P, Tetzlaff MT, Wargo JA, Jenq RR.

Nat Med. 2019 Jan;25(1):188. doi: 10.1038/s41591-018-0305-2.


Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis.

Wang Y, Wiesnoski DH, Helmink BA, Gopalakrishnan V, Choi K, DuPont HL, Jiang ZD, Abu-Sbeih H, Sanchez CA, Chang CC, Parra ER, Francisco-Cruz A, Raju GS, Stroehlein JR, Campbell MT, Gao J, Subudhi SK, Maru DM, Blando JM, Lazar AJ, Allison JP, Sharma P, Tetzlaff MT, Wargo JA, Jenq RR.

Nat Med. 2018 Dec;24(12):1804-1808. doi: 10.1038/s41591-018-0238-9. Epub 2018 Nov 12. Erratum in: Nat Med. 2018 Nov 27;:.


Immune-Related Thyroiditis with Immune Checkpoint Inhibitors.

Iyer PC, Cabanillas ME, Waguespack SG, Hu MI, Thosani S, Lavis VR, Busaidy NL, Subudhi SK, Diab A, Dadu R.

Thyroid. 2018 Oct;28(10):1243-1251. doi: 10.1089/thy.2018.0116.


Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers.

Sharma A, Subudhi SK, Blando J, Scutti J, Vence L, Wargo J, Allison JP, Ribas A, Sharma P.

Clin Cancer Res. 2019 Feb 15;25(4):1233-1238. doi: 10.1158/1078-0432.CCR-18-0762. Epub 2018 Jul 27.


Modulation of EZH2 expression in T cells improves efficacy of anti-CTLA-4 therapy.

Goswami S, Apostolou I, Zhang J, Skepner J, Anandhan S, Zhang X, Xiong L, Trojer P, Aparicio A, Subudhi SK, Allison JP, Zhao H, Sharma P.

J Clin Invest. 2018 Aug 31;128(9):3813-3818. doi: 10.1172/JCI99760. Epub 2018 Jul 30.


Patient-Derived Xenograft Tumor Models: Overview and Relevance to IR.

Sheth RA, Perkons N, Dondossola E, Subudhi SK, Gade TP, Tam AL.

J Vasc Interv Radiol. 2018 Jun;29(6):880-882.e1. doi: 10.1016/j.jvir.2018.01.782. Review. No abstract available.


Current and Future Applications of Novel Immunotherapies in Urological Oncology: A Critical Review of the Literature.

Özdemir BC, Siefker-Radtke AO, Campbell MT, Subudhi SK.

Eur Urol Focus. 2018 Apr;4(3):442-454. doi: 10.1016/j.euf.2017.10.001. Epub 2017 Oct 19. Review.


Immunotherapy for metastatic prostate cancer: immuno-cold or the tip of the iceberg?

Laccetti AL, Subudhi SK.

Curr Opin Urol. 2017 Nov;27(6):566-571. doi: 10.1097/MOU.0000000000000433. Review.


Clinical predictors of survival in patients with castration-resistant prostate cancer receiving sipuleucel-T cellular immunotherapy.

Bilen MA, Hess KR, Subudhi SK, Aparicio A, Kim J, Zurita-Saavedra AJ, Araujo JC, Corn PG, Stover J, Lin SH, Logothetis CJ, Tu SM.

Cancer Chemother Pharmacol. 2017 Sep;80(3):583-589. doi: 10.1007/s00280-017-3391-9. Epub 2017 Jul 20.


VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer.

Gao J, Ward JF, Pettaway CA, Shi LZ, Subudhi SK, Vence LM, Zhao H, Chen J, Chen H, Efstathiou E, Troncoso P, Allison JP, Logothetis CJ, Wistuba II, Sepulveda MA, Sun J, Wargo J, Blando J, Sharma P.

Nat Med. 2017 May;23(5):551-555. doi: 10.1038/nm.4308. Epub 2017 Mar 27.


Stepwise case selection using Guy's stone score reduces complications during percutaneous nephrolithotomy training.

Jaipuria J, Suryavanshi M, Desai AP, Goyal S, Patel K, Parhad SS, Subudhi SK, Rao CV, Kumar SP, Sen TK.

Indian J Urol. 2017 Jan-Mar;33(1):41-47. doi: 10.4103/0970-1591.195757.


Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities.

Subudhi SK, Aparicio A, Gao J, Zurita AJ, Araujo JC, Logothetis CJ, Tahir SA, Korivi BR, Slack RS, Vence L, Emerson RO, Yusko E, Vignali M, Robins HS, Sun J, Allison JP, Sharma P.

Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):11919-11924. Epub 2016 Oct 3.


Beyond Seed and Soil: Understanding and Targeting Metastatic Prostate Cancer; Report From the 2016 Coffey-Holden Prostate Cancer Academy Meeting.

Miyahira AK, Roychowdhury S, Goswami S, Ippolito JE, Priceman SJ, Pritchard CC, Sfanos KS, Subudhi SK, Simons JW, Pienta KJ, Soule HR.

Prostate. 2017 Feb;77(2):123-144. doi: 10.1002/pros.23260. Epub 2016 Sep 28. Review.


Retrospective Analysis of Different Bracket Systems used in the Treatment of Patients with Anterior Crowding: A Longitudinal Comparative Study.

Sepolia S, Kushwah AP, Natt AS, Vashisht L, Sahoo SK, Subudhi SK.

J Contemp Dent Pract. 2016 Aug 1;17(8):687-91.


Comparative Evaluation of Pediatric Patients with Mental Retardation undergoing Dental Treatment under General Anesthesia: A Retrospective Analysis.

Ahuja R, Jyoti B, Shewale V, Shetty S, Subudhi SK, Kaur M.

J Contemp Dent Pract. 2016 Aug 1;17(8):675-8.


Evaluation of Outcome of Orthodontic Treatment in Context to Posttreatment Stability: A Retrospective Analysis.

Kanuru RK, Mangat SS, Sepolia G, Subudhi SK, Asnani MM, Bansal A.

J Contemp Dent Pract. 2016 Jul 1;17(7):587-91.


Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapy.

Shi LZ, Fu T, Guan B, Chen J, Blando JM, Allison JP, Xiong L, Subudhi SK, Gao J, Sharma P.

Nat Commun. 2016 Aug 8;7:12335. doi: 10.1038/ncomms12335.


Acute rhabdomyolysis with severe polymyositis following ipilimumab-nivolumab treatment in a cancer patient with elevated anti-striated muscle antibody.

Bilen MA, Subudhi SK, Gao J, Tannir NM, Tu SM, Sharma P.

J Immunother Cancer. 2016 Jun 21;4:36. doi: 10.1186/s40425-016-0139-8. eCollection 2016.


Immune Checkpoint Therapies in Prostate Cancer.

Goswami S, Aparicio A, Subudhi SK.

Cancer J. 2016 Mar-Apr;22(2):117-20. doi: 10.1097/PPO.0000000000000176. Review.


Supracostal percutaneous nephrolithotomy: A prospective comparative study.

Sinha M, Krishnappa P, Subudhi SK, Krishnamoorthy V.

Indian J Urol. 2016 Jan-Mar;32(1):45-9. doi: 10.4103/0970-1591.173121.


Emergence of micronuclei as a genomic biomarker.

Sabharwal R, Verma P, Syed MA, Sharma T, Subudhi SK, Mohanty S, Gupta S.

Indian J Med Paediatr Oncol. 2015 Oct-Dec;36(4):212-8. doi: 10.4103/0971-5851.171541. Review.


A novel approach for retreatment of multirooted tooth by partial radisection.

Malhotra G, Kataria P, Shukla P, Gupta S, Sargaiyan V, Mahendra A, Subudhi SK.

Ann Afr Med. 2015 Jan-Mar;14(1):69-72. doi: 10.4103/1596-3519.148751.


Association between use of tobacco and age on graying of hair.

Sabharwal R, Gupta A, Moon N, Mahendra A, Sargaiyan V, Gupta A, Subudhi SK, Gupta S.

Niger J Surg. 2014 Jul;20(2):83-6. doi: 10.4103/1117-6806.137308.


An Insight in to Paget's Disease of Bone.

Sabharwal R, Gupta S, Sepolia S, Panigrahi R, Mohanty S, Subudhi SK, Kumar M.

Niger J Surg. 2014 Jan;20(1):9-15. doi: 10.4103/1117-6806.127098. Review.


Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy.

Zamarin D, Holmgaard RB, Subudhi SK, Park JS, Mansour M, Palese P, Merghoub T, Wolchok JD, Allison JP.

Sci Transl Med. 2014 Mar 5;6(226):226ra32. doi: 10.1126/scitranslmed.3008095.


Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade.

Arora VK, Schenkein E, Murali R, Subudhi SK, Wongvipat J, Balbas MD, Shah N, Cai L, Efstathiou E, Logothetis C, Zheng D, Sawyers CL.

Cell. 2013 Dec 5;155(6):1309-22. doi: 10.1016/j.cell.2013.11.012.


Prostate cancer progression correlates with increased humoral immune response to a human endogenous retrovirus GAG protein.

Reis BS, Jungbluth AA, Frosina D, Holz M, Ritter E, Nakayama E, Ishida T, Obata Y, Carver B, Scher H, Scardino PT, Slovin S, Subudhi SK, Reuter VE, Savage C, Allison JP, Melamed J, Jäger E, Ritter G, Old LJ, Gnjatic S.

Clin Cancer Res. 2013 Nov 15;19(22):6112-25. doi: 10.1158/1078-0432.CCR-12-3580. Epub 2013 Sep 30.


A whole-blood RNA transcript-based prognostic model in men with castration-resistant prostate cancer: a prospective study.

Ross RW, Galsky MD, Scher HI, Magidson J, Wassmann K, Lee GS, Katz L, Subudhi SK, Anand A, Fleisher M, Kantoff PW, Oh WK.

Lancet Oncol. 2012 Nov;13(11):1105-13. doi: 10.1016/S1470-2045(12)70263-2. Epub 2012 Oct 9.


Response to "Ipilimumab (Yervoy) and the TGN1412 catastrophe".

Curran MA, Callahan MK, Subudhi SK, Allison JP.

Immunobiology. 2012 Jun;217(6):590-2. doi: 10.1016/j.imbio.2011.11.001. Epub 2011 Nov 17. No abstract available.


Improving the therapeutic benefits of ipilimumab.

Subudhi SK, Callahan MK, Wolchok JD.

Oncology (Williston Park). 2010 Dec;24(14):1288, 1294. No abstract available.


Contribution of the lymphotoxin beta receptor to liver regeneration.

Anders RA, Subudhi SK, Wang J, Pfeffer K, Fu YX.

J Immunol. 2005 Jul 15;175(2):1295-300.


The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses.

Wang Y, Subudhi SK, Anders RA, Lo J, Sun Y, Blink S, Wang Y, Wang J, Liu X, Mink K, Degrandi D, Pfeffer K, Fu YX.

J Clin Invest. 2005 Mar;115(3):711-7.


The balance of immune responses: costimulation verse coinhibition.

Subudhi SK, Alegre ML, Fu YX.

J Mol Med (Berl). 2005 Mar;83(3):193-202. Epub 2005 Jan 4. Review.


The human BCL6 transgene promotes the development of lymphomas in the mouse.

Baron BW, Anastasi J, Montag A, Huo D, Baron RM, Karrison T, Thirman MJ, Subudhi SK, Chin RK, Felsher DW, Fu YX, McKeithan TW, Baron JM.

Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14198-203. Epub 2004 Sep 16.


Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection.

Subudhi SK, Zhou P, Yerian LM, Chin RK, Lo JC, Anders RA, Sun Y, Chen L, Wang Y, Alegre ML, Fu YX.

J Clin Invest. 2004 Mar;113(5):694-700.


Co-stimulation agonists as a new immunotherapy for autoimmune diseases.

Sun Y, Subudhi SK, Fu YX.

Trends Mol Med. 2003 Nov;9(11):483-9. Review.


Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells.

Tang Q, Henriksen KJ, Boden EK, Tooley AJ, Ye J, Subudhi SK, Zheng XX, Strom TB, Bluestone JA.

J Immunol. 2003 Oct 1;171(7):3348-52.


Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease.

Sun Y, Chen HM, Subudhi SK, Chen J, Koka R, Chen L, Fu YX.

Nat Med. 2002 Dec;8(12):1405-13. Epub 2002 Nov 11.


The Src family kinase Fyn mediates signals induced by TCR antagonists.

Tang Q, Subudhi SK, Henriksen KJ, Long CG, Vives F, Bluestone JA.

J Immunol. 2002 May 1;168(9):4480-7.

Supplemental Content

Loading ...
Support Center